The International Journal of Antibiotics (IJAB) is a leading peer-reviewed publication, providing a platform for researchers and clinicians to share pioneering research in the field of antibiotics. Launched in 2024, this biannual journal is committed to advancing our understanding of antibiotic resistance, the development of new antibiotics, and the clinical and pharmacological aspects of antibiotic therapy.
Why Choose IJAB?
1. Focus on Antibiotic Resistance: Antibiotic resistance poses a significant threat to global health. IJAB prioritizes research that addresses this critical issue, offering insights into the mechanisms of resistance and strategies to combat it.
2. Innovation in Antibiotic Development: The journal highlights groundbreaking research in the discovery and development of new antibiotics. By fostering innovation, IJAB aims to support the creation of novel treatments to fight resistant pathogens.
3. Comprehensive Coverage: From clinical pharmacology to antimicrobial stewardship, IJAB covers a broad spectrum of topics. Researchers and practitioners can find valuable information on antibiotic therapy, microbial resistance, and effective antibiotic policies.
4. Open Access and Peer-Reviewed: IJAB is an open-access journal, ensuring that all research is freely available to the global community. The rigorous peer-review process guarantees the publication of high-quality, impactful research.
Submission Guidelines
Researchers interested in contributing to IJAB can find detailed submission guidelines on the journal’s website. The guidelines include information on manuscript preparation, the submission process, and adherence to publication ethics. Authors are encouraged to submit original research articles, comprehensive review articles, and thought-provoking perspectives.
Industry Impact
With the growing challenge of antibiotic resistance, the demand for reliable and innovative research is more crucial than ever. IJAB serves as a critical resource for professionals in the medical and scientific communities, providing the latest findings and developments in antibiotic research.
Stay Updated
Stay ahead in the field of antibiotics by subscribing to IJAB. Receive updates on the latest research, special issues, and opportunities to contribute. Whether you’re a researcher, clinician, or student, IJAB offers valuable insights and advancements that can enhance your knowledge and practice.
For more information and to submit your manuscript, visit the International Journal of Antibiotics website.
Industry Information and References
- Companies and Institutions:
- Pharmaceutical companies involved in antibiotic development.
- Research institutions focusing on infectious diseases and antimicrobial resistance.
- Clinical laboratories conducting antibiotic susceptibility testing.
- Market Data:
- The global antibiotics market size was valued at USD 45.58 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.4% from 2022 to 2030.
- Job and Career Opportunities:
- Careers in pharmaceutical research and development.
- Clinical research positions in hospitals and healthcare institutions.
- Academic roles in universities focusing on microbiology and pharmacology.
Table:
| Journal Title | Website URL | Journal Features | Focus & Scope URL | Author Guidelines URL | Manuscript Submission URL |
| International Journal of Antibiotics | IJAB | Peer-reviewed, Open Access, Biannual | Focus & Scope | Author Guidelines | Submit Manuscript |
By choosing the International Journal of Antibiotics, you’re joining a community dedicated to advancing antibiotic research and combating one of the most pressing health challenges of our time